Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 17Rectal Neoplasms 9Triple Negative Breast Neoplasms 7Stomach Neoplasms 7Colorectal Neoplasms 6Adenocarcinoma 6Neoplasm Metastasis 5Esophageal Neoplasms 5Adenocarcinoma Of Esophagus 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Pancreatic Neoplasms 4Nasopharyngeal Carcinoma 4Neoplasms 3Esophageal Squamous Cell Carcinoma 2Carcinoma 2Biliary Tract Neoplasms 2Advanced Solid Tumour 2Solid Tumors 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Locally Advanced Gastric Cancer 1HIV Infections 1HER2-positive Gastric Cancer 1HER2-positive Breast Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1

Interventions

paricalcitol 1Positron Emission Tomography Computed Tomography 1Parturition 1Oxaliplatin 1Neoadjuvant Therapy 1Losartan 1Leucovorin 1Irinotecan 1Hydroxychloroquine 1Gemcitabine 1Fluorouracil 1Fecal Microbiota Transplantation 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Ductal Adenocarcinoma × Capecitabine × 30 days × Clear all
NCT07024615 2026-05-28

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Astellas Pharma Inc

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡